Cleveland Clinic Cancer Advances

Investigating Mitochondria Transfer for Glioblastoma

August 31, 2023 Cleveland Clinic Taussig Cancer Institute
Investigating Mitochondria Transfer for Glioblastoma
Cleveland Clinic Cancer Advances
More Info
Cleveland Clinic Cancer Advances
Investigating Mitochondria Transfer for Glioblastoma
Aug 31, 2023
Cleveland Clinic Taussig Cancer Institute
The Cancer Advances podcast is joined by Justin Lathia, PhD, Melvin H. Burkhardt Endowed Chair for Neuro-Oncology Research, Scientific Director of the Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center, and the Vice Chair of the Department of Cardiovascular and Metabolic Sciences at Cleveland Clinic's Lerner Research Institute to talk about his study on mitochondria transfer for glioblastoma. Listen as Dr. Lathia shares the complexity of glioblastomas, the challenges in treating it, and the potential of mitochondria transfer as a communication process.
Show Notes
The Cancer Advances podcast is joined by Justin Lathia, PhD, Melvin H. Burkhardt Endowed Chair for Neuro-Oncology Research, Scientific Director of the Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center, and the Vice Chair of the Department of Cardiovascular and Metabolic Sciences at Cleveland Clinic's Lerner Research Institute to talk about his study on mitochondria transfer for glioblastoma. Listen as Dr. Lathia shares the complexity of glioblastomas, the challenges in treating it, and the potential of mitochondria transfer as a communication process.